WallStSmart

Accendra Health Inc (ACH)vsCardinal Health Inc (CAH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 8758% more annual revenue ($244.67B vs $2.76B). CAH leads profitability with a 68.0% profit margin vs -39.9%. ACH appears more attractively valued with a PEG of 0.70. CAH earns a higher WallStSmart Score of 53/100 (C-).

ACH

Hold

45

out of 100

Grade: D+

Growth: 2.7Profit: 3.0Value: 6.7Quality: 5.0

CAH

Buy

53

out of 100

Grade: C-

Growth: 7.3Profit: 7.5Value: 8.7Quality: 5.8
Piotroski: 4/9Altman Z: 4.30
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ACH.

CAHUndervalued (+13.6%)

Margin of Safety

+13.6%

Fair Value

$259.58

Current Price

$207.83

$51.75 discount

UndervaluedFair: $259.58Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACH1 strengths · Avg: 8.0/10
PEG RatioValuation
0.708/10

Growing faster than its price suggests

CAH4 strengths · Avg: 9.5/10
Profit MarginProfitability
68.0%10/10

Keeps 68 of every $100 in revenue as profit

Operating MarginProfitability
123.0%10/10

Strong operational efficiency at 123.0%

Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
18.8%8/10

18.8% revenue growth

Areas to Watch

ACH4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$180.39M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.9%3/10

Operating margin of 2.9%

Return on EquityProfitability
-163.8%2/10

ROE of -163.8% — below average capital efficiency

CAH2 concerns · Avg: 3.5/10
P/E RatioValuation
30.3x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ACH

The strongest argument for ACH centers on PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.

Bull Case : CAH

The strongest argument for CAH centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 68.0% and operating margin at 123.0%. Revenue growth of 18.8% demonstrates continued momentum.

Bear Case : ACH

The primary concerns for ACH are EPS Growth, Market Cap, Operating Margin.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity.

Key Dynamics to Monitor

ACH profiles as a turnaround stock while CAH is a growth play — different risk/reward profiles.

ACH carries more volatility with a beta of 1.29 — expect wider price swings.

CAH is growing revenue faster at 18.8% — sustainability is the question.

CAH generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

CAH scores higher overall (53/100 vs 45/100), backed by strong 68.0% margins and 18.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accendra Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Want to dig deeper into these stocks?